Todos Medical (OTCMKTS:TOMDF) and Modular Medical (NASDAQ:MODD) Head-To-Head Survey

Todos Medical (OTCMKTS:TOMDF) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Todos Medical and Modular Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Todos Medical	0	0	0	0	0.00
Modular Medical	0	0	1	0	3.00

Modular Medical has a consensus target price of $5.00, indicating a potential upside of 120.26%. Given Modular Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Modular Medical is more favorable than Todos Medical.

Valuation & Earnings

This table compares Todos Medical and Modular Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Todos Medical	$12.23 million	0.02	-$43.31 million	N/A	N/A
Modular Medical	N/A	N/A	-$17.47 million	($0.68)	-3.34

Modular Medical has lower revenue, but higher earnings than Todos Medical.

Institutional & Insider Ownership

27.5% of Modular Medical shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Todos Medical and Modular Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Todos Medical	N/A	N/A	N/A
Modular Medical	N/A	-228.12%	-178.09%

Risk and Volatility

Todos Medical has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500.

Summary

Modular Medical beats Todos Medical on 7 of the 10 factors compared between the two stocks.

About Todos Medical

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.